CAN
BLPH

Cetera Advisor Networks’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Cetera Advisor Networks’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-900
Closed -$11K – 3428
2020
Q2 		$11K Buy
+900
New +$12.6K ﹤0.01% 2697

Other funds holding BLPH

PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's BLPH Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2020, closing a stake of 900 shares — an estimated $11K sold.

Cetera Advisor Networks first reported a position in BLPH in Q2 2020 and held it in 1 quarter. The position peaked at $11K in Q2 2020. 41 funds tracked by Wall St. Rank hold BLPH as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 900 Bellerophon Therapeutics, Inc. shares in Q3 2020, an estimated $11K.
  • Cetera Advisor Networks first reported a position in Bellerophon Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Bellerophon Therapeutics, Inc. position peaked at $11K in Q2 2020.
  • 41 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.